ArticleRadiological physics and technology2026
Comparative dosimetry study of PARaDIM and RT-PHITS with ICRP publication 128: calculation of organ doses from
Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates organ doses from ¹⁸F-FDG whole-body PET-CT using the phantom-based software PARaDIM and patient image-based software RT-PHITS and compares with reference data from ICRP Publication 128. Absorbed dose coefficients (mGy/MBq) were calculated using ICRP Publication 145 mesh-type phantoms in PARaDIM and 20 patient datasets (10 male, 10 female) from 'The Cancer Imaging Archives' website in RT-PHITS. Organs were segmented in 3D Slicer, and dose coefficients were derived after physical decay correction of the resultant dose rates (mGy/s). The patient cohort (n = 20; 10 males, 10 females) had an average age of 52.1 years, height of 172.1 cm, weight of 76.65 kg, and total administered activity of 306.55 MBq. Absorbed dose coefficients from PARaDIM and RT-PHITS ranged from 0.01 to 0.07 mGy/MBq. RT-PHITS showed acceptable agreement with ICRP 128 and PARaDIM for most organs, except for the urinary bladder and heart wall. Standard deviations (SD) for RT-PHITS urinary bladder doses were 0.04 relative to ICRP 128 and 0.12 relative to PARaDIM; heart wall SDs were 0.016 and 0.014, respectively. Overall, RT-PHITS organ doses yielded an average SD of 0.0073, with the highest deviation in the heart wall. The results indicate that anatomical differences lead to measurable variations between the generalized and individualized dosimetry methodologies. Because a consistent physical decay model of
Indexed as
Identifiers
42627587What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.